Our commitment is clear: to shift the paradigm on drug affordability while upholding the highest standards of quality, safety, and efficacy. Here are the key priorities which steer us towards our goals.
CONTACT
Group Companies
OUR KEY PRIORITIES
Patient centricity
We discover, develop and deliver affordable, innovative medicines that help our patients prevail over serious diseases. Their well-being and convenience are top priority for us. Biocon’s innovative science and products have disrupted the healthcare process in developed countries that saw life-saving medicines accessible to only a few. We are committed to respecting the patient community’s independence and to working in a simple, transparent way.
Purpose-Driven
At Biocon, we are a globally aligned team inspired by a shared vision and strong leadership, united in our mission to transform global health. By delivering safe, effective, and high-quality biosimilars and generics, we are committed to expanding equitable access to essential medicines for patients everywhere. As we navigate a complex healthcare landscape, we harness our scientific depth and technological strength to drive progress and evolve into a leading global innovator in healthcare. Every step we take is guided by our dedication to driving positive social and environmentally sustainable impact that contributes to a healthier world.
Lab-to-Patient
Biocon’s fully integrated lab-to-patient model empowers us to deliver critical medicines swiftly and reliably across 120+ countries. By collaborating with partners and healthcare systems and leveraging our global scale, we expand patient access efficiently. Our investment in end-to-end capabilities—from R&D to manufacturing to commercialization—ensures a seamless experience and a resilient supply chain. With manufacturing sites across multiple geographies, we operate with agility, responsiveness, and flexibility. Bold decisions, like the Viatris acquisition, reflect our commitment to challenging conventional paths and earning stakeholder trust through consistent delivery and innovation.
Focus on Science
Research & Development forms the bedrock of Biocon’s mission to deliver affordable therapeutics that address unmet patient needs. Our primary focus is on diabetes, cancer and autoimmune diseases. However, we constantly adapt and track the latest insights, to let science show us the way forward. Biocon’s core R&D philosophy is focussed on developing select high potential molecules that are at the forefront of technological innovation. We use deep science and cutting-edge R&D to create disruptive solutions and offer affordable alternatives to some of the world’s most expensive medicines.
Global Impact
In an environment where pricing and access remain key challenges, Biocon plays a pivotal role by providing high-quality biosimilars and generics to treat serious conditions like diabetes, cancer, obesity, and autoimmune diseases.
Our deep expertise across generics and biosimilars empowers us to meet evolving market needs. United by a shared purpose and driven by the courage to lead, we are working toward a bold ambition: to reach a billion patients with affordable, life-changing medicines.
Access to all
Nearly 2 billion people, a third of the world’s population, lack access to essential medicines; and where healthcare does exist, it is unaffordable. It is time to shift the debate from high-priced, advanced therapeutics to affordable innovation, from market strategies to medical solutions, from mitigating cost to unlocking value. In doing so, we aim to deliver our medicines to as many people as possible and create better patient outcomes. By leveraging India’s scientific advantage, we are moderating costs and widening patient access through high-quality specialty products for chronic ailments such as diabetes, cancer and autoimmune diseases.
Quality First
We are committed to maintaining the highest quality standards. Our regulatory and quality systems are robust, best-in-class and of global standards. They have earned us the trust of patients, doctors, caregivers, partners and healthcare ecosystems around the world.
Quality First
We are committed to maintaining the highest quality standards. Our regulatory and quality systems are robust, best-in-class and of global standards. They have earned us the trust of patients, doctors, caregivers, partners and healthcare ecosystems around the world.
Sustainable Growth
We believe that real, sustainable growth is possible when industry interests are balanced with societal interests. We aim to make a difference by changing the healthcare dynamics and making high-quality, affordable medicine accessible to more than a billion people. Our strong sense of ethics drives us in creating long-term value for all our stakeholders.
Sustainable Growth
We believe that real, sustainable growth is possible when industry interests are balanced with societal interests. We aim to make a difference by changing the healthcare dynamics and making high-quality, affordable medicine accessible to more than a billion people. Our strong sense of ethics drives us in creating long-term value for all our stakeholders.
People Power
Our people are our biggest asset. They fuel innovation in our pipeline and hold true to our commitment of exploring the unexplored in medicine. Our deep-rooted entrepreneurial culture attracts the brightest talent. We strive to maintain an environment that values our diverse workforce, constantly motivating them to realise their full potential.
People Power
Our people are our biggest asset. They fuel innovation in our pipeline and hold true to our commitment of exploring the unexplored in medicine. Our deep-rooted entrepreneurial culture attracts the brightest talent. We strive to maintain an environment that values our diverse workforce, constantly motivating them to realise their full potential.
PRODUCTS
BUSINESSES
